Comparison of Intralase and Visumax Femtosecond Laser for Laser In Situ Keratomileusis

Sponsor
Singapore Eye Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT01252654
Collaborator
(none)
45
1
43
1

Study Details

Study Description

Brief Summary

Emtosecond lasers are used in cutting the flap in LASIK procedures (laser corrective surgery for refractive error). Their use has decreased the incidence of serious complications when compared to the use of microkeratomes(mechanical blades). The commonest femtosecond laser currently used is 'Intralase'. A newer femtosecond laser 'Visumax' (Zeiss) is now available and differs from the Intralase in that it does not interfere with the curvature of the cornea when creating the flap. The Intralase applanates the cornea flat during flap creation which causes the intraocular pressure to be higher. Both Intralase and Visumax lasers are available to patients and surgeons to use at SNEC. The aim of the investigators study is to compare the two lasers in a randomization of left and right eyes in the same patient. The investigators want to measure any difference that the lower intraocular pressure may have during the creation of the flap. This will be measured with a questionaire on patient experience during the procedure and the outcomes of vision, refraction, contrast sensitivity, wave-front analysis, tear function,corneal sensation and flap thickness measured with anterior segment OCT during the post-operative follow up period. To date no-one has compared the use of these two femtosecond lasers. Both lasers are currently used clinically for flap creation at SNEC.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    45 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Study Start Date :
    Jan 1, 2010
    Actual Primary Completion Date :
    Aug 1, 2012
    Actual Study Completion Date :
    Aug 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    1 IntraLase flaps

    Patients who have undergone flap creation with IntraLase laser

    2 Visumax flaps

    Patients who have undergone flaps created with Visumax laser

    Outcome Measures

    Primary Outcome Measures

    1. Visual Acuity [3 months]

    Secondary Outcome Measures

    1. complications [3 months]

    2. Subjective questionnaire [1 weekd]

    3. Corneal Sensation [3 months]

    4. Tear function [3 months]

    5. Wavefront analysis [3 months]

    6. Contrast Sensitivity [3 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 21 years of age or older.

    • Cycloplegic spherical equivalent of >-1.00D

    • Refractive cylinder -4.00 D or less.

    • Best spectacle corrected visual acuity (BSCVA) of 6/12 or better in BOTH eyes.

    • Spherical or cylindrical error has progressed at -0.50D or less per year from date of baseline measurement.

    • Contact lens wearers must have removed contact lenses at least two (2) weeks before the baseline measurement.

    • No evidence of irregular astigmatism on corneal topography.

    • Available to attend post-operative examinations for a 3 month period.

    Exclusion Criteria:
    • Progressive or unstable myopia and/or astigmatism.

    • Clinical or corneal topographic evidence of keratoconus.

    • Residual, recurrent or active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract and retinal disease.

    • Previous corneal surgery or trauma within the corneal flap zone.

    • Patent corneal vascularization within 1mm of the corneal flap zone.

    • Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites.

    • Systemically immunocompromised.

    • Systemic disease likely to affect wound healing, such as diabetes, connective tissue disease and severe atopy.

    • Pregnant or nursing.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Singapore National Eye Centre Singapore Singapore 168751

    Sponsors and Collaborators

    • Singapore Eye Research Institute

    Investigators

    • Principal Investigator: Donald Tan, Singapore National Eye Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jodhbir Mehta, Head Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute
    ClinicalTrials.gov Identifier:
    NCT01252654
    Other Study ID Numbers:
    • R683/33/2009
    • Other
    First Posted:
    Dec 3, 2010
    Last Update Posted:
    Jul 20, 2016
    Last Verified:
    Jul 1, 2016
    Keywords provided by Jodhbir Mehta, Head Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 20, 2016